limited stage
Showing 1 - 25 of >10,000
Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,
Not yet recruiting
- Limited Stage Lung Small Cell Carcinoma
- +3 more
- Cisplatin
- +8 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Nov 10, 2023
Limited-stage Small Cell Lung Cancer (LS-SCLC) Trial in Jinan (Tifcemalimab injection, toripalimab injection, Placebo for
Not yet recruiting
- Limited-stage Small Cell Lung Cancer (LS-SCLC)
- Tifcemalimab injection
- +3 more
-
Jinan, Shandong, ChinaShandong Cancer Hospital & Institute
Oct 18, 2023
Limited Stage Small Cell Lung Cancer, Not Progressed After First-line Chemoradiotherapy Trial in Jinan (TQB2450 Injection +
Recruiting
- Limited Stage Small Cell Lung Cancer
- Not Progressed After First-line Chemoradiotherapy
- TQB2450 Injection + Anlotinib Hydrochloride Capsules
-
Jinan, Shandong, ChinaCancer Hospital Affiliated to Shandong First Medical University
Jul 5, 2023
Small Cell Lung Cancer Limited Stage Trial (Prophylactic cranial irradiation, Thoracic radiotherapy, Chemotherapy)
Not yet recruiting
- Small Cell Lung Cancer Limited Stage
- Prophylactic cranial irradiation
- +2 more
- (no location specified)
Dec 14, 2022
Limited Stage Small Cell Lung Cancer Trial (HLX10, hypofractionated radiotherapy, Prophylactic Cranial Irradiation (PCI))
Not yet recruiting
- Limited Stage Small Cell Lung Cancer
- HLX10
- +2 more
- (no location specified)
Jun 29, 2022
Limited Stage Small Cell Lung Cancer Trial in Shang'ai (chemo and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy)
Not yet recruiting
- Limited Stage Small Cell Lung Cancer
- chemotherapy and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy
-
Shang'ai, Shanghai, ChinaShanghai Pulmonary Hospital
Aug 8, 2022
Limited Stage Small Cell Lung Cancer Trial in Shanghai (Pamiparib)
Recruiting
- Limited Stage Small Cell Lung Cancer
-
Shanghai, Shanghai, China
- +1 more
Jul 29, 2022
Molecular Analysis and Treatment Options of SCLC
Recruiting
- Small-cell Lung Cancer
- +4 more
-
Shanghai, ChinaShanghai Chest Hospital
Jul 6, 2023
Lung Tumors Trial (Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy), Envafolimab combined
Not yet recruiting
- Lung Neoplasms
- Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy)
- Envafolimab combined with concurrent chemoradiotherapy (Conventional Radiotherapy)
- (no location specified)
Jun 12, 2023
Limited Stage Small Cell Lung Cancer Trial in Guangzhou (Sugemalimab, Placebo)
Not yet recruiting
- Limited Stage Small Cell Lung Cancer
- Sugemalimab
- Placebo
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 12, 2022
Lung Cancer Trial in Manchester (Once daily radiotherapy, Twice daily radiotherapy)
Completed
- Lung Cancer
- Once daily radiotherapy
- Twice daily radiotherapy
-
Manchester, United KingdomThe Christie NHS Foundation Trust
Sep 5, 2022
Oral Squamous Cell Carcinoma Trial in Beijing (Toripalimab)
Not yet recruiting
- Oral Squamous Cell Carcinoma
-
Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Apr 5, 2023
Limited Stage Small Cell Lung Cancer Trial in Beijing (Durvalumab)
Recruiting
- Limited Stage Small Cell Lung Cancer
-
Beijing, ChinaBeijing Haidian Hospital
Sep 1, 2021
Hepatocellular Carcinoma (HCC) Trial in Taiwan, United States (IA therapy of HCC with CSR02-Fab-TF)
Recruiting
- Hepatocellular Carcinoma (HCC)
- IA therapy of HCC with CSR02-Fab-TF
-
Saint Louis, Missouri
- +6 more
Aug 16, 2022
Lymphoma, Non-Hodgkin's, Adult Trial in Rosario, Caba (Evaluation of first line treatment in patients with stage I and II LBCL)
Recruiting
- Lymphoma, Non-Hodgkin's, Adult
- Evaluation of first line treatment in patients with stage I and II LBCL
-
Paraná, Entre Ríos, Argentina
- +6 more
Dec 29, 2022
Small Cell Lung Cancer Limited Stage Trial in Tianjin (Concurrent chemoradiotherapy plus anlotinib)
Recruiting
- Small Cell Lung Cancer Limited Stage
- Concurrent chemoradiotherapy plus anlotinib
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
May 7, 2021
Lymphoma, Extranodal NK-T-Cell Trial in Shanghai (Pembrolizumab, Involved Field Radiation Therapy)
Recruiting
- Lymphoma, Extranodal NK-T-Cell
- Pembrolizumab
- Involved Field Radiation Therapy
-
Shanghai, ChinaShanghai Rui-Jin Hospital
Mar 29, 2022
Carcinoma, Small Cell Lung Trial in China (Atezolizumab, Tiragolumab, Placebo)
Active, not recruiting
- Carcinoma, Small Cell Lung
- Atezolizumab
- +2 more
-
Beijing City, China
- +20 more
Dec 15, 2022
Breast Cancer, Prostate Cancer, Colorectal Cancer Trial in United States (Exercise)
Recruiting
- Breast Cancer
- +11 more
- Exercise
-
San Carlos, California
- +7 more
Aug 24, 2022
Ovarian Cancer, Ovarian Carcinoma, Stage II Ovary Cancer Trial in United States (Mind-body resilience training, Music therapy,
Recruiting
- Ovarian Cancer
- +13 more
- Mind-body resilience training
- +3 more
-
Basking Ridge, New Jersey
- +6 more
Jun 28, 2022
Small Cell Lung Cancer Limited Stage Trial in Germany (Durvalumab, standard of care)
Recruiting
- Small Cell Lung Cancer Limited Stage
- Durvalumab
- standard of care
-
Löwenstein, Baden-Würtemberg, Germany
- +9 more
May 18, 2022
Adenocarcinoma of the Lung, Extensive Stage Small Cell Lung Cancer, Limited Stage Small Cell Lung Cancer Trial in Aurora
Completed
- Adenocarcinoma of the Lung
- +7 more
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Jan 19, 2022
Limited Stage Small Cell Lung Cancer Trial in Jinan (MRI Surveillance, Prophylactic Cranial Irradiation)
Recruiting
- Limited Stage Small Cell Lung Cancer
- MRI Surveillance
- Prophylactic Cranial Irradiation
-
Jinan, Shandong, China
- +1 more
Apr 28, 2021
Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage III Soft Tissue Sarcoma of the Trunk and Extremities
Recruiting
- Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
- +3 more
- Chest Radiography
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 28, 2022